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Background: Local anticoagulation services are inadequate and substantially underutilized despite compelling 
evidence showing that their appropriate use significantly reduces the risk of thromboembolic complications.  
Objectives: To determine the predictors of adequate ambulatory anticoagulation services in Kenyatta National 
Hospital.  
Methodology: A cross sectional study between December 2014 and April 2015 among 102 adult outpatients on 
anticoagulation using consecutive sampling was done. Information abstracted into a predesigned data collection tool 
included participants’ sociodemographic characteristics, regular sources of supply of anticoagulant, clinic pre-
appointment reminders, indications of treatment and international normalized ratio tests. Data were analyzed using 
IBM Statistical Package for Social Sciences version 21.0 and logistic regression was used to determine independent 
predictors of adequate anticoagulation, which was defined as international normalized ratio ranging 2 - 3.  
Results: Females were majority (76.5 %) and only 27.5 % of patients  had adequate anticoagulation control. The 
indication of warfarin for heart valve surgery (p=0.014) and deep venous thrombosis (p=0.021) were associated with 
adequate anticoagulation. Age above 60 years was associated with poor anticoagulation (p=0.006). Logistic regression 
revealed that the independent predictor of adequate anticoagulation was warfarin use due to heart valve surgery 
(OR=3.1; 95% CI: 1.2 – 7.9, p=0.017). 
Conclusions: Ambulatory anticoagulation control in the hospital is poor. Further investigation is required to find out 
the reasons behind adequate anticoagulation in heart valve surgery patients.  
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1. Introduction 
Anticoagulation medications are high risk treatments 
that commonly require complex dosing and monitoring 
of effects to optimize therapy (Ageno et al, 2012). 
Vitamin K antagonists (VKA), for example warfarin, are 
the most widely prescribed ambulatory anticoagulants 
in Kenya (Ogendo, 2000) and the rest of the world 
(Pham and Pham, 2007). Despite their effectiveness, 
VKAs  have unpredictable and highly variable effect in 
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coagulation, with a high risk of under and over-
treatment (Ageno et al, 2012).  The activity of these 
ambulatory anticoagulants has to be closely monitored 
by maintaining the international normalized ratio (INR) 
between 2-3 and to ensure an adequate yet safe dose is 
taken (Ansell et al, 2004; Pham and Pham, 2007).  
Dosing of warfarin is complicated by the fact that it has 
a narrow therapeutic index (Holbrook et al, 2012). 
Consequently, in order to optimize its therapeutic effect 
without risking dangerous side effects such as bleeding, 
close monitoring of the degree of anticoagulation is 
required (Gage et al, 2006) as well as identification of 
other factors which could impact on therapy. 
Globally, unavailability of  local clinical guidelines has 
been suggested to contribute to suboptimal therapy as  
their appropriate utilization improves the process and 
outcomes of anticoagulation (Ageno et al, 2012). 
Furthermore, lack of protocols  may also hinder 
translation of knowledge into clinical practice 
(Grimshaw and Russell, 1993). In addition, 
anticoagulation could substantially be underutilized, 
especially in the absence of local clinical guidelines 
(Ageno et al, 2012), as it is in our setting. 
Locally, several studies have revealed that ambulatory 
anticoagulation control is poor (Kibiru, 2012; Mariita et 
al, 2016; Ogendo, 2000). Some studies have implicated 
patient factors such as poor knowledge on 
anticoagulation and sociodemographic variables  
(Mariita et al, 2016) while others point towards poor 
warfarin dosing methods (Ogendo, 2000). These studies 
suggest that independent predictors which could 
optimize anticoagulation services need to be sought to 
avoid fatal and disabling complications such as bleeding 
disorders associated with VKAs (Seet et al, 2013). 
Furthermore, compelling evidence shows that 
appropriate use of anticoagulation services significantly 
reduces the risk of thromboembolic complications and 
all-cause mortality (De Caterina et al, 2012).   
This study sought to determine the factors which can 
predict adequate ambulatory anticoagulation practices 
at the Kenyatta National Hospital (KNH) with a view to 
improving the practice. 
2. Methods 
2.1 Study Design and Area 
This was cross-sectional study conducted at KNH, the 
largest teaching and referral hospital in Kenya that also 
serves as a primary healthcare facility for the 
communities around it. Data were collected from KNH 
cardiothoracic surgery, haemato-oncology and medical 
clinics where most of the patients on long term warfarin 
therapy are managed. In addition, anticoagulation 
referrals of patients requiring specialized care on 
anticoagulation therapy are usually to the three clinics. 
In the year 2012 alone, there were 2467 and 8202 
outpatients in cardiothoracic and haemato-oncology 
clinic, respectively.  
2.2  Study Population 
The study was carried out among male and female 
patients. Only freely consenting patients were invited to 
participate in the study. Patients were eligible if they 
were on warfarin therapy, had attained at least 18 years 
of age and signed written, informed consent. Patients 
were excluded if they had a contraindication of warfarin 
therapy such as peptic ulcer disease and pregnancy. 
2.3  Sample Size and Sampling Method 
The primary endpoint of the current study was the 
proportion of patients with adequate anticoagulation 
controls (appropriate INRs of 2-3). Local studies on 
anticoagulation control had revealed that only 6.9 % of 
patients were able to maintain adequate 
anticoagulation for ≥ 50 % of their follow up time 
(Ogendo, 2000), therefore, a prevalence of 6.9 % was 
used for sample size estimation.  By using  Cochran 
equation (Cochran, 2007) to yield a representative 
sample for the population, the sample size was 
estimated  at ninety eight but a 10 % was added to cater 
for data losses and non-responders to get a sample of 
110 patients. Patients were recruited consecutively as 
they came for their appointments during the clinic days.  
2.4  Data collection 
Patients were recruited on the day they came for clinic 
appointments after they had been attended by the 
clinician. Once they consented, the questionnaire was 
administered. Every study tool was allocated a unique 
alphanumeric serial number to avoid confusion and 
duplication of the data. Demographic characteristics 
including age, gender, education level, marital status 
and details of warfarin therapy such as indication as 
well as regular sources of drug supply were obtained 
through patient interviews and a review of patients’ 
files by researcher.  
Once the patient had been taken through recruitment, 
consenting and the questionnaire administration, 
he/she was handed over to a trained, qualified and 
experienced phlebotomist who was in charge of 
drawing the blood specimens for INR determination. 
This was done at the haemato-oncology clinic bleeding 
centre. The sample was immediately put in a vacutainer 
with citrate, labelled with the serial number 
corresponding to the participant’s questionnaire and 
taken for INR testing in the University of Nairobi 
haematology laboratory. INR testing was done within 2 
hours to prevent haemolysis which could give 
erroneous readings. The results of INR were 
immediately communicated to the attending clinicians 
for decision making on warfarin dose adjustments. 
2.5  Data Entry and Statistical Analysis 
Data collected was captured into the computer database 
using Microsoft Access version 2013. It was then 
exported to IBM Statistical package for social sciences 
(SPSS) version 21 for analysis. All data was verified 
before analysis. 
Exploratory data analysis was carried out to describe 
the study population in terms of socio-demographic and 
clinical characteristics. Descriptive statistics were done 
for categorical variables such as gender, education level, 
marital status and warfarin indications. For continuous 
variable such as age, anticoagulation measurement and 
doses of warfarin, measures of central tendency 
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including mean, standard deviations, median, ranges 
were used. Anticoagulation control for each patient was 
reflected by the measured INR value being within, 
below or above the therapeutic range of 2-3 as 
recommended in the international guidelines (Ageno et 
al, 2012). Bivariate analysis was done to determine 
associations between predictor and outcome variables. 
Chi-squared tests were adopted to determine the 
association of outcome variables with nominal factors. 
To adjust for potential confounders, stepwise backward 
binary logistic regression model was used starting with 
initial predictors of INR control on bivariate analysis to 
determine independent predictors of adequate 
ambulatory anticoagulation. Odds ratios (ORs) were 
computed and statistical significance was set at 95% 
confidence limit. Values with p ≤0.05 were considered 
statistically significant.  
 
       Figure 1: Flow diagram showing patient eligibility and reasons for exclusion 
 
       Table 1: Socio-demographic Characteristics of the Study Patients (N=102)       
Variable Category n % 
Gender Male 24 23.5 
 Female 78 76.5 
Mean Age in years (SD) 42.0 (± 13.4)   
Age group(Years) 18 - 30  24 23.8 
31 - 40 22 21.8 
41 - 50 33 32.7 
51 - 60  14 13.9 
>60  8 8.0 
Marital status Single 26 25.5 
Married 59 57.8 
Divorced 8 7.8 
Widowed 9 8.8 
Occupation Unemployed 27 26.5 
Salaried 33 32.4 
Self-employed 40 39.2 
Student 2 2.0 
Education Level College /University 24 23.5 
Secondary 41 40.2 
Primary 17 16.7 
Non –formal 20 19.6 
       Key: SD-Standard Deviation 
  
Ambulatory Patients on 
Oral Anticoagulation 
 
(N=110 Patients) 
Excluded (n=8) 
Reasons: 
 Less than 18 years (n=1) 
 Patients had stopped taking the 
warfarin (n=3) 
 Peptic Ulcer Disease (n=3) 
 Declined to participate(n=1) 
Study Group (eligible) 
 (n = 102) 
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2.6 Ethical considerations 
Study approval was obtained from Kenyatta National 
Hospital/University of Nairobi Ethics and Research 
Committee (KNH/UoN-ERC) and study reference 
number KNH-ERC/A/280 was given. All patients 
provided informed consent prior to recruitment. All the 
information acquired was treated in strictest confident 
without sharing with the third party. The filled study 
forms were filed and locked securely where only the 
researcher had access. 
3. Results  
A total of one hundred and ten participants were 
screened. However, data were analyzed from 102 
participants because eight participants were not eligible 
due to various reasons (Figure 1). 
The mean age (SD) of the study population was 
42.0(±13.4) years. There was female predominance at 
78(76.5 %). Majority of the participants were self-
employed (39.2 %) and had attained secondary level of 
education (40.2 %) (Table 1). 
The main indication of warfarin among the study 
participants was for managing DVT at 57 (55.9%) 
followed by major surgery (39.2 %) and rheumatic 
heart disease (8.8 %). Other less common uses included 
atrial fibrillation, pulmonary embolism and 
cerebrovascular events, all accounting for 5.9 %. Three 
quarters of the patients were getting their regular drug 
supply from outside the hospital (Table 2). 
The study sought to find out what reminds the patients 
of the next clinic appointment as this could have an 
impact on the level of anticoagulation control among 
the patients. Almost three-quarters of the patient used 
the calendar as a reminder for their next clinic 
appointments. Those who relied on their clinic cards 
and caregivers as reminders for the appointments 
accounted for 13% and 10%, respectively. The rest 
were using mobile alerts (3%), relatives (1%) or diaries 
(1%) as reminders for the next clinic appointment 
(Figure 2). 
At the time of the study, almost a third (27.5%) of the 
participants had INR levels within therapeutic range of 
2-3 (Figure 3). 
Table 2: Indications and Sources of Warfarin Supply 
Indications of Warfarin n % Sources of  Warfarin n % 
DVT 57 55.9 Last Supply   
Major Surgery (Valve repair/replacement) 40 39.2 KNH 21 24.4 
RHD 9 8.8 Other sources 65 75.6 
Atrial Fibrillation 3 2.9 Regular Supply   
Pulmonary Embolism 1 1.0 KNH 21 24.1 
Other Indications (CVAs) 2 2.0 Other sources 66 75.9 
*CVAs-Cerebral Vascular Accidents; DVT-Deep Vein Thrombosis; KNH-Kenyatta National Hospital; RHD-Rheumatic Heart Disease. 
 
          Figure 2: Clinic pre-appointments reminders 
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Bivariate analysis was done to determine relationships 
between the predictor and outcome variables. 
Demographic characteristics, sources of warfarin 
supply, indications of the drug and patients’ reminders 
were explored to determine the factors which impacted 
on anticoagulation control. Patients’ age was 
statistically significantly associated with the level of 
anticoagulation, with most patients above 60 years 
being outside therapeutic INR (p=0.006). Patients’ 
marital status, occupation and sources of warfarin 
supply did not show any statistically significant 
relationship with the level of anticoagulation (P>0.05). 
The proportion of males with adequate anticoagulation 
control was higher than that of females but this was not 
statistically significantly associated with the level of 
anticoagulation (p=0.217). There was no statistically 
significant difference between the patients’ clinic 
appointment reminder mechanisms and the level of 
anticoagulation control (p>0.05). 
There was statistically significant relationship between 
the level of anticoagulation control and patients who 
had had DVT (p=0.021) and major surgery (p=0.014) 
(Table 3). Stepwise backward binary logistic regression 
model was used starting with age group, clinic card 
reminder, major surgery and DVT as initial predictors of 
adequate INR control on bivariate analysis. Patients 
who had undergone major surgery were three times 
more likely to have adequate INR control than those 
who had not (OR=3.1 95% CI of OR [1.2 – 7.9], p=0.017). 
       Figure 3: Level of anticoagulation control at the time of study 
 
  Table 3: Relationship between levels of anticoagulation control versus indications for warfarin therapy 
Indications of Warfarin 
INR Control 
p-value INR controlled INR not controlled 
n % n  % 
Major Surgery No 10 16.1 52 83.9 0.014 
Yes 15 37.5 25 62.5  
DVT No 16 35.6 29 64.4 0.021 
Yes 9 15.8 48 84.2  
Pulmonary Embolism No 25 24.8 76 75.2 0.567 
Yes 0 0 1 100.0  
RHD No 21 22.6 72 77.4 0.145 
Yes 4 44.4 5 55.6  
Atrial Fibrillation No 24 24.2 75 75.8 0.718 
Yes 1 33.3 2 66.7  
Transient Ischaemic Attacks No 25 24.5 77 75.5 - 
Yes 0 0 0 0.0  
Key: DVT-Deep Vein Thrombosis; INR- International Normalized Ratio; RHD-Rheumatic Heart Disease. Major surgery included 
valve repair or valve replacement. 
4.0 Discussion 
This study has revealed that ambulatory patients who 
received anticoagulation due to DVT or heart valve 
surgery were better anticoagulated. Utilization of 
anticoagulation to prevent thrombosis among patients 
who have undergone heart valve surgery has been 
associated with optimal INR control (Mariita et al, 
2016).  Unlike other participants, this group of patients 
was using predesigned cards as clinic appointment 
reminders which could have facilitated the 
improvement in the observed anticoagulation 
control.Patients’ appointment reminder systems 
improve patients' adherence to screening, diagnosis, 
Nyamu et al, Afr. J. Pharmacol. Ther. 2017. 6(1): 20-26 
 
A KeSoBAP Publication ©2017. All rights reserved. 
25 
and treatment. Studies have revealed that pre-
appointment patients’ reminders proved sensible and 
beneficial additions to treatment programme (Liu et al, 
2014).  
We observed that, unlike for other warfarin indications, 
patients who had undergone heart valve surgery were 
using the predesigned clinic pre-appointment cards 
which contained detailed information on warfarin use. 
This suggested that these patients had opportunities to 
understand and monitor their treatments unlike their 
counterparts, thus giving them a benefit of optimal 
control. Additionally, there are also possibilities that 
previous reports (Ogendo, 2000)  on poor 
anticoagulation control among the heart surgery 
patients led to improvement in anticoagulation services.  
The proportion of adequately anticoagulated patients in 
our study was low at 27.5% though comparable with 
25% found in Malaysia (Yahaya, 2009), 33% in Saudi 
Arabia (Mayet, 2015) and 31 % previously (Kibiru, 
2012). Although our figure was low, it represents an 
improvement from a previous study done in the same 
hospital which found adequate anticoagulation at 6.9 % 
(Ogendo, 2000). Probably the fact that latter study used 
the Rosendaal method that has been reported to 
underestimate INR (Schmitt et al, 2003) was the reason 
for  the small proportion of adequately anticoagulated 
patients. Additionally, Ogendo et al (2000) only 
reported the proportion of patients who achieved 
adequate anticoagulation for 50% or more of the follow 
up time.  Our finding, however, contrasts another study 
done by  Khudair et al, which showed 41% of their 
patients having INRs within range (Khudair and 
Hanssens, 2010).  
Our study revealed female predominance at 76.5%, 
although gender did not impact on the level of 
anticoagulation. Several studies on anticoagulation 
control have shown similar female preponderance and 
young population aged around 40 years (Davis et al, 
2005; Kibiru, 2012; Mayet, 2015; Ogendo, 2000). These 
findings are probable because it has been suggested 
that most of the conditions requiring anticoagulation 
start developing from the age of 40 years(Cushman, 
2007). However, poor anticoagulation control was more 
common among the elderly patients (> 60 years) 
(p=0.006). Khan et al have revealed that the elderly 
patients are more likely to be poorly 
anticoagulated(Khan et al, 2004). Similarly, Paralleti et 
al (Tran et al, 2014) in a case-control study in Italy 
found that the odds ratio of INR instability was 
significantly higher in those who had poor 
comprehension of anticoagulation therapy, as may be 
seen in elderly. Contrary Witt et al found that elderly 
patients above 70 years and on chronic anticoagulation 
had more stable INRs (Witt et al, 2009). 
Warfarin was used mostly for the management of DVT 
(55.9 %) and prevention of complications associated 
with heart valve surgery (39.2%). Similar findings were 
revealed by other local studies (Kibiru, 2012; Mariita et 
al, 2016). Kibiru found the prevalence of DVT and heart 
valve surgery at 66% and 21 % (Kibiru, 2012) while 
Mariita found 48.6% and 32.9 % (Mariita et al, 2016), 
respectively. Although there were slight variations in 
the proportions observed, those were the main 
indications for warfarin anticoagulation. The 
differences in the proportions may have been attributed 
to differences in study periods which could have 
affected the patients’ appointment schedules. 
Slightly over three quarters of the patients who 
indicated their regular sources of drug supply got their 
medicine from facilities outside the hospital. Probably 
long queues at the hospital pharmacies could have 
influenced the choice of where to purchase the drugs. 
Sources of warfarin, however, could not predict the 
adequacy of anticoagulation among patients. 
The main limitation in our study was that as common 
with cross-sectional studies that involve interviews, 
patients may have underreported or over reported their 
experiences but this was minimized by counterchecking 
information from patients’ files. Secondly, we relied on 
single measurement of INR. 
5.0 Conclusion  
Ambulatory anticoagulation with vitamin K antagonists 
still remains poor in KNH with almost 75% of the 
patients being inadequately anticoagulated, especially 
the elderly. However, optimal anticoagulation control 
was associated with prevention of thromboembolic 
disorder following heart valve surgery. Further 
investigation is required to find out why patients with 
heart valve surgery are better anticoagulated than 
others. Larger studies, however, should be carried out 
to explore the prescriber and hospital contextual factors 
which may impact on anticoagulation. 
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